반려동물용 백신 시장 규모, 점유율, 동향 분석 보고서 : 동물 유형별, 제품별, 투여 경로별, 유통 채널별, 제품별, 지역별, 부문 예측(2025-2030년)

Companion Animal Vaccines Market Growth & Trends:

The global companion animal vaccines market size is expected to reach USD 6.27 billion by 2030, growing at a CAGR of 8.25% during the forecast period, according to a new report by Grand View Research, Inc. The growing trend of pet ownership, along with the increasing humanization of pets where they are treated as beloved family members continues to fuel market growth. According to the 2023-2024 APPA National Pet Owners Survey, 66% of U.S. households, or approximately 86.9 million, own a pet. As pets are seen as integral family members, owners are more inclined to invest in their health through vaccinations and veterinary care, boosting demand for both core and non-core vaccines. Pet humanization also results in more knowledgeable pet owners who recognize the importance of adhering to vaccination schedules, ensuring their dogs receive timely and essential immunizations.

Pet insurance companies have a valuable opportunity to stimulate growth in the companion animal vaccines market by expanding their coverage to include a wider range of veterinary services. By incorporating wellness care, routine vaccinations, dental treatments, behavioral therapy, and alternative therapies such as acupuncture, laser therapy, and chiropractic care into their insurance plans, these companies can appeal to a growing segment of pet owners who prioritize holistic and preventative healthcare for their animals.

This shift toward more comprehensive coverage encourages pet owners to engage more frequently in regular veterinary visits, where vaccines both core and non-core are often administered as part of routine care. As a result, demand for companion animal vaccines increases. For instance, MetLife Pet Insurance already supports this trend by reimbursing policyholders for vaccinations, and other alternative treatments, provided they are veterinarian-administered and covered under the policy. This type of coverage promotes early intervention and preventive healthcare, which includes vaccinations, ultimately driving growth in the vaccine segment by making such services more accessible and affordable.

Market players play a critical role in driving the growth of the companion animal vaccines market by investing in research and development, expanding product portfolios, forming strategic partnerships, and entering new geographic markets. These efforts help meet the rising demand for effective and innovative vaccines as pet ownership and awareness about animal health increase globally. For instance, Merck Animal Health (MSD), in 2024, received USDA approval for NOBIVAC(R) NXT Canine Flu H3N2, the first canine influenza vaccine using RNA-particle technology. This is a major technological milestone, providing enhanced immune response with low-volume, adjuvant-free doses.

Companion Animal Vaccines Market Report Highlights:

• In 2024, the canine segment dominated the market with the largest revenue share, owing to the increased dog population and rising dog ownership globally.
• The attenuated live vaccines segment dominated the companion animal vaccines market with a share of over 37.00% in 2024, whereas the recombinant vaccine segment is anticipated to grow at the fastest CAGR over the forecast period.
• The subcutaneous segment dominated the market with a largest revenue share of over 41.0% in 2024, due to its ease of application and reduced risk of adverse reactions.
• Hospital/clinic pharmacy held the largest revenue share of the companion animal vaccines market in 2024
• The North American region accounted for a largest revenue share of over 28% in 2024. The region is experiencing strong growth due to rising pet ownership

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased Database
  • 1.3.2. GVR's Internal Database
  • 1.3.3. Secondary Sources
  • 1.3.4. Primary Research
• 1.4. Information/Data Analysis
• 1.5. Market Formulation & Visualization
• 1.6. Data Validation & Publishing
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis
  • 1.7.2. Global Market: CAGR Calculation
• 1.8. List of Secondary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Companion Animal Vaccines Market Variable Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market
  • 3.1.2. Ancillary Market
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising pet population
    • 3.2.1.2. Increasing disease outbreak
    • 3.2.1.3. Rising R&D and manufacturing advancements
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Lack of awareness
    • 3.2.2.2. Complex regulations
  • 3.2.3. Market Opportunity Analysis
  • 3.2.4. Market Challenge Analysis
• 3.3. Companion Animal Vaccines Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitution
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal landscape
    • 3.3.2.2. Economic and Social landscape
    • 3.3.2.3. Technological landscape
    • 3.3.2.4. Environmental landscape
  • 3.3.3. Regulatory Framework
  • 3.3.4. Pricing Analysis
  • 3.3.5. Disease Prevalence Analysis
  • 3.3.6. Estimated Animal Population by key countries, key species, 2024
  • 3.3.7. Product Pipeline Analysis

Chapter 4. Companion Animal Vaccines Market: Animal Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Companion Animal Vaccines Market: Animal type Movement Analysis
• 4.3. Companion Animal Vaccines Market Size & Trend Analysis, by animal type, 2018 to 2030 (USD Million)
• 4.4. Canine
  • 4.4.1. Canine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.5. Feline
  • 4.5.1. Feline Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Others
  • 4.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Companion Animal Vaccines Market: By Product Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Companion Animal Vaccines Market: By Product Movement Analysis
• 5.3. Companion Animal Vaccines Market Size & Trend Analysis, by product, 2018 to 2030 (USD Million)
  • 5.3.1. Attenuated Live Vaccines
    • 5.3.1.1. Attenuated Live Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.3.2. Inactivated Vaccines
    • 5.3.2.1. Inactivated Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.3.3. Subunit Vaccines
    • 5.3.3.1. Subunit Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.3.4. DNA Vaccines
    • 5.3.4.1. DNA Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.3.5. Recombinant Vaccines
    • 5.3.5.1. Recombinant Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Companion Animal Vaccines Market: By Route of Administration Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Companion Animal Vaccines Market: By Route of Administration Movement Analysis
• 6.3. Companion Animal Vaccines Market Size & Trend Analysis, by route of administration, 2018 to 2030 (USD Million)
  • 6.3.1. Subcutaneous
    • 6.3.1.1. Subcutaneous Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.2. Intramuscular
    • 6.3.2.1. Intramuscular Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.3. Intranasal
    • 6.3.3.1. Intranasal Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Companion Animal Vaccines Market: By Distribution Channel Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Companion Animal Vaccines Market: By Distribution Channel Movement Analysis
• 7.3. Companion Animal Vaccines Market Size & Trend Analysis, by distribution channel, 2018 to 2030 (USD Million)
  • 7.3.1. Retail
    • 7.3.1.1. Retail Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3.2. E-Commerce
    • 7.3.2.1. E-Commerce Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3.3. Hospital/Clinic Pharmacy
    • 7.3.3.1. Hospital/Clinic Pharmacy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Companion Animal Vaccines Market: Regional Estimates & Trend Analysis

• 8.1. Regional Dashboard
• 8.2. Companion Animal Vaccines Market Share, By Region, 2024 & 2030, USD Million
• 8.3. Regional Outlook
• 8.4. North America
  • 8.4.1. North America Companion Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.4.2. U.S.
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. U.S. Companion Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.4.3. Canada
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Canada Companion Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.4.4. Mexico
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. Mexico Companion Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 8.5. Europe
  • 8.5.1. Europe Companion Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.2. UK
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. UK Companion Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.3. Germany
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Germany Companion Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.4. France
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. France Companion Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.5. Italy
    • 8.5.5.1. Key Country Dynamics
    • 8.5.5.2. Italy Companion Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.6. Spain
    • 8.5.6.1. Key Country Dynamics
    • 8.5.6.2. Spain Companion Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.7. Denmark
    • 8.5.7.1. Key Country Dynamics
    • 8.5.7.2. Denmark Companion Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.8. Sweden
    • 8.5.8.1. Key Country Dynamics
    • 8.5.8.2. Sweden Companion Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.9. Norway
    • 8.5.9.1. Key Country Dynamics
    • 8.5.9.2. Norway Companion Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 8.6. Asia Pacific
  • 8.6.1. Asia Pacific Companion Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6.2. Japan
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Japan Companion Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6.3. China
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. China Companion Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6.4. India
    • 8.6.4.1. Key Country Dynamics
    • 8.6.4.2. India Companion Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6.5. Australia
    • 8.6.5.1. Key Country Dynamics
    • 8.6.5.2. Australia Companion Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6.6. South Korea
    • 8.6.6.1. Key Country Dynamics
    • 8.6.6.2. South Korea Companion Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6.7. Thailand
    • 8.6.7.1. Key Country Dynamics
    • 8.6.7.2. Thailand Companion Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 8.7. Latin America
  • 8.7.1. Latin America Companion Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.7.2. Brazil
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Brazil Companion Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.7.3. Argentina
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Argentina Companion Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 8.8. Middle East & Africa
  • 8.8.1. Middle East & Africa Companion Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.8.2. South Africa
    • 8.8.2.1. Key Country Dynamics
    • 8.8.2.2. South Africa Companion Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.8.3. Saudi Arabia
    • 8.8.3.1. Key Country Dynamics
    • 8.8.3.2. Saudi Arabia Companion Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.8.4. UAE
    • 8.8.4.1. Key Country Dynamics
    • 8.8.4.2. UAE Companion Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.8.5. Kuwait
    • 8.8.5.1. Key Country Dynamics
    • 8.8.5.2. Kuwait Companion Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Market Participant Categorization
• 9.2. Company Market Position Analysis/ Heap Map Analysis
• 9.3. Company Profiles
  • 9.3.1. Merck & Co., Inc.
    • 9.3.1.1. Participant's Overview
    • 9.3.1.2. Financial Performance
    • 9.3.1.3. Product Benchmarking
    • 9.3.1.4. Strategic Initiatives
  • 9.3.2. Zoetis
    • 9.3.2.1. Participant's Overview
    • 9.3.2.2. Financial Performance
    • 9.3.2.3. Product Benchmarking
    • 9.3.2.4. Strategic Initiatives
  • 9.3.3. Virbac
    • 9.3.3.1. Participant's Overview
    • 9.3.3.2. Financial Performance
    • 9.3.3.3. Product Benchmarking
    • 9.3.3.4. Strategic Initiatives
  • 9.3.4. Elanco
    • 9.3.4.1. Participant's Overview
    • 9.3.4.2. Financial Performance
    • 9.3.4.3. Product Benchmarking
    • 9.3.4.4. Strategic Initiatives
  • 9.3.5. Boehringer Ingelheim Animal Health
    • 9.3.5.1. Participant's Overview
    • 9.3.5.2. Financial Performance
    • 9.3.5.3. Product Benchmarking
    • 9.3.5.4. Strategic Initiatives
  • 9.3.6. Phibro Animal Health Corporation
    • 9.3.6.1. Participant's Overview
    • 9.3.6.2. Financial Performance
    • 9.3.6.3. Product Benchmarking
    • 9.3.6.4. Strategic Initiatives
  • 9.3.7. Calier
    • 9.3.7.1. Participant's Overview
    • 9.3.7.2. Financial Performance
    • 9.3.7.3. Product Benchmarking
    • 9.3.7.4. Strategic Initiatives
  • 9.3.8. Ceva
    • 9.3.8.1. Participant's Overview
    • 9.3.8.2. Financial Performance
    • 9.3.8.3. Product Benchmarking
    • 9.3.8.4. Strategic Initiatives
  • 9.3.9. Bimeda Biologicals
    • 9.3.9.1. Participant's Overview
    • 9.3.9.2. Financial Performance
    • 9.3.9.3. Product Benchmarking
    • 9.3.9.4. Strategic Initiatives
  • 9.3.10. Neogen Corporation
    • 9.3.10.1. Participant's Overview
    • 9.3.10.2. Financial Performance
    • 9.3.10.3. Product Benchmarking
    • 9.3.10.4. Strategic Initiatives
• 9.4. Strategy Mapping
  • 9.4.1. Mergers & Acquisitions
  • 9.4.2. Partnerships & Collaborations
  • 9.4.3. Expansion
  • 9.4.4. Product launch
  • 9.4.5. Product Approval
  • 9.4.6. Others
• 9.5. List of other key players